Inventor
Robert G. L. Shorr
Inventor
Edison, NJ, US
Overview
Patents· 47 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
C07KPeptides14%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
C12NMicroorganisms or enzymes6%
Y02ATechnologies for adaptation to climate change4%
B82BNanostructures formed by manipulation of individual atoms, molecules, or limited collections of atoms or molecules as discrete units3%
C07CAcyclic or carbocyclic compounds2%
C07DHeterocyclic compounds2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
PatentTitleYear
11,065,335Methods of treating leukemia using compositions containing bis(benzylthio)octanoic acid and ion pairs thereof202110,526,357Pharmaceutical compounds202010,450,337Pharmaceutical compounds201910,391,177Methods for treating cancer using 6,8-bis (benzylthio) octanonic acid201910,179,796Pharmaceutical compounds201910,098,955Pharmaceutical formulations containing lipoic acid derivatives20189,872,845Methods of treating myeloma and lymphoma using compositions containing an ion pair of a lipoic acid derivative20189,839,691'Methods of treating pancreatic and ovarian cancers using compositions containing an ion pair of a lipoic acid derivative'20179,320,726'Methods of treating colon, lung, and liver cancers using compositions containing an ion pair of a lipoic acid derivative'20168,691,873'Pharmaceutical formulations containing lipoic acid derivatives'20148,263,653'Pharmaceutical formulations containing lipoic acid derivatives'2012RE043295'Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells'20127,632,504'Polyalkylene oxide-modified single chain polypeptides'20097,537,885'Composition for maintaining organ and cell viability'20097,521,066'Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells'20097,387,790'Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells'20087,220,428'Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells'20077,220,538'Composition for maintaining organ and cell viability'20077,150,872'Polyalkylene oxide-modified single chain polypeptides'20066,872,393'Polyalkylene oxide-modified single chain polypeptides'20056,824,782'Polyalkylene oxide-modified single chain polypeptides'20046,803,386'Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer'20046,743,908'Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof'20046,743,896'Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof'20046,323,322'Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof'20016,242,482'Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failure'20016,013,283'Alkyl or olefinic endcapped polyalkylene oxide solubilizer'20005,900,402'Method of reducing side effects associated with administration of oxygen-carrying proteins'19995,786,154'Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis'19985,767,260'Antigen-binding fusion proteins'19985,763,733'Antigen-binding fusion proteins'19985,728,560'Method of treating CD4+ T cell lymphopenia in immuno-compromised patients'19985,705,153'Glycolipid enzyme-polymer conjugates'19985,686,110'Water soluble complex of an alkyl or olefinic end capped polyalkylene oxide and a water insoluble substance'19975,650,388'Fractionated polyalkylene oxide-conjugated hemoglobin solutions'19975,620,884'Glycolipid enzyme-polymer conjugates'19975,580,968'DNA encoding phospholipase activating protein'19965,527,775'Reduction of mammalian neoplasms with phospholipase A2 activating substances'19965,478,805'Fractionation of polyalkylene oxide-conjugated hemoglobin solutions'19955,428,128'Site specific synthesis of conjugated peptides'19955,367,063'Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis'19945,312,808'Fractionation of polyalkylene oxide-conjugated hemoglobin solutions'19945,294,698'Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis'19945,264,555'Process for hemoglobin extraction and purification'19935,219,923'Electrophoretic media'19935,153,166'Chromatographic stationary supports'19925,055,517'Electrophoretic media'1991Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1991–1993Based in Overbrook Hills, PA, US· patent location history
1993–2009Patents assigned to ENZON INC (19)· patent assignee history
1993–2021Based in Edison, NJ, US· patent location history
1994–1998Based in Wynnewood, PA, US· patent location history
2007–2009Patents assigned to CORNERSTONE PHARMACEUTICALS (3)· patent assignee history
2012–2017Patents assigned to CORNERSTONE PHARMACEUTICALS INC (5)· patent assignee history
2012–2014Patents assigned to RODRIGUEZ ROBERT J (3)· patent assignee history
2017–2021Patents assigned to RAFAEL PHARMACEUTICALS INC (8)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ENZON INC | 19 | 1993–2009 |
| RAFAEL PHARMACEUTICALS INC | 8 | 2017–2021 |
| CORNERSTONE PHARMACEUTICALS INC | 5 | 2012–2017 |
| CORNERSTONE PHARMACEUTICALS | 3 | 2007–2009 |
| RODRIGUEZ ROBERT J | 3 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Edison, New Jersey, US | 40 | 1993–2021 |
| Wynnewood, Pennsylvania, US | 4 | 1994–1998 |
| Overbrook Hills, Pennsylvania, US | 3 | 1991–1993 |